First compulsory licence application in India
Indian generic drug maker Natco has filed a compulsory licence application for the patent covering German pharma company Bayer’s anti-cancer drug Nexavar
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: